Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine

Brain Research

Volumn 847, Issue 1, 1999, Pages 139-142

  Alburges, Mario E ^a   Hanson, Glen R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Cocaine; Dynorphin; Ibogaine; Neurotensin; Nucleus accumbens; Striatum

Indexed keywords

COCAINE; DYNORPHIN; IBOGAINE; NEUROTENSIN;

ANIMAL MODEL; ANIMAL TISSUE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SHORT SURVEY; SUBSTANTIA NIGRA;

EID: 0032753248     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02017-X     Document Type: Article

References (18)

1. Alburges M.E., Hanson G.R. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine. Brain Res. 818:1999;96-104.
2. Cappendijk S.L., Dzoljic M.R. Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur. J. Pharmacol. 214:1993;261-265.
3. Carlezon W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
4. Gershom S., Lang W.J. A psycho-pharmacological study of some indole alkaloids. Arch. Int. Pharmacodyn. 135:1962;31-56.
5. Hanson G.R., Merchant K.M., Letter A.A., Gibb J.W. Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur. J. Pharmacol. 155:1988;11-18.
6. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
7. H.S. Lotsof, Rapid method for interrupting the cocaine and amphetamine abuse syndrome, U.S. patent 4,587,243, 1986.
8. Lotsof H.S. Ibogaine in the treatment of chemical dependency disorders: clinical perspectives. Multidisciplinary Association for Psychedelic Studies. 5:1995;16-27.
9. Nego S.S., Mello N.K., Portoghese P.S., Lin C.E. Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 282:1997;44-55.
10. Popik P., Layer R.T., Skolnick P. The putative anti-addictive drug ibogaine is a competitive inhibitor of [3-H] MK-801 binding to the NMDA receptor complex. Psychopharmacology. 114:1994;672-674.
11. Sershen H., Hashim A., Harsing L.G. Jr., Lajtha A. Ibogaine antagonizes cocaine-induced locomotor stimulation in mice. Life Sci. 50:1992;1079-1086.
12. Sershen H., Hashim A., Lajtha A. Ibogaine reduces preference for cocaine consumption in C57BL/6By mice. Pharmacol. Biochem. Behav. 47:1994;13-19.
13. Sershen H., Hashim A., Lajtha A. Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats. Neurochem. Res. 19:1994;1463-1466.
14. Sheppard S.G. A preliminary investigation of ibogaine: case reports and recommendations for further study. J. Subst. Abuse Treat. 11:1994;379-385.
15. Sisko B. Interrupting drug dependency with ibogaine: a summary of four case histories. Multidisciplinary Association for Psychedelic Studies. 4:1993;15-24.
16. Smiley P., Johnson M., Bush L., Gibb J.W., Hanson G.R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253:1990;938-943.
17. Spangler R., Ho A., Zhou Y., Maggos C., Yuferov V., Kreek M.J. Regulation of kappa opioid receptor mRNA in the rat brain by 'binge' pattern cocaine administration and correlation with preprodynorphin mRNA. Mol. Brain Res. 38:1996;71-76.
18. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.